We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,202.60
Bid: 1,202.40
Ask: 1,202.80
Change: -13.40 (-1.10%)
Spread: 0.40 (0.03%)
Open: 1,202.20
High: 1,236.80
Low: 1,201.20
Yest. Close: 1,216.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

London open: Lloyds beats forecasts but markets fall ahead of long weekend

London stocks fell on Friday despite a better-than-expected first quarter from Lloyds Banking Group as investors were treading carefully in the absence of trading across Europe. The FTSE 100 was down 0.51% at 6,924.94 early on, with most equity markets on the continent closed for May Day. Analyst C

1 May 15 09:05

BROKER RATINGS SUMMARY: Berenberg Cuts Barclays To Sell From Hold

1 May 15 08:34

Glaxo and Theravance win FDA approval for Breo asthma treatment

Glaxosmithkline (GSK) has said its Breo once-daily treatment for adult asthma has been approved by the US Food and Drug Administration (FDA). Breo, developed with US pharmaceutical group Theravance, is a "fixed-dose combination of the inhaled corticosteroid (ICS) fluticasone furoate (FF) and the lon

1 May 15 07:54

LONDON MORNING BRIEFING: Lloyds Banking Results Please Market

1 May 15 07:29

LONDON MARKET COMMENT: Stocks Seen Lower; Lloyds Pretax Profit Falls

1 May 15 06:34

GlaxoSmithKline Says US FDA Approves Breo Ellipta For Asthma In Adults

1 May 15 06:07

AGM, EGM Calendar - Week Ahead

1 May 15 05:12

Earnings, Trading Statements Calendar - Week Ahead

1 May 15 05:12

U.S. FDA approves Glaxo, Theravance's Breo Ellipta asthma drug

April 30 (Reuters) - The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma in patients aged 18 and older, GlaxoSmithKline and Theravance Inc said. The FDA declined to approve Breo for younger asthma sufferers. The agency, in

30 Apr 15 21:31

UPDATE 1-Nexium, Advair led Medicare drug spending in 2013 -officials

(New throughout, adds more prescribing data and details of neurology drug price rise) By Sharon Begley NEW YORK, April 30 (Reuters) - Four brand-name medications accounted for almost one-tenth of the $103 billion in prescriptions filled by older or disabled Americans under Medicare's

30 Apr 15 20:50

Nexium, Advair led Medicare drug spending in 2013 - officials

By Sharon Begley NEW YORK, April 30 (Reuters) - Four brand-named drugs prescribed to older or disabled Americans covered by Medicare's drug benefit accounted for almost one-tenth of the $103 billion in prescriptions filled under the plan in 2013, U.S. officials reported on Thursday. T

30 Apr 15 19:52

GSK's Nigerian unit says Q1 pretax profit falls 53 pct

LAGOS, April 30 (Reuters) - GSK's Nigerian unit said on Thursday its first-quarter pretax profit fell 52.7 percent to 421.83 million naira ($2 million), from a year earlier. Revenue also fell to 7.45 billion naira in the period to end-March from 7.80 billion naira last year, the pharmaceut

30 Apr 15 16:30

AGM, EGM Calendar - Week Ahead

30 Apr 15 15:10

Earnings, Trading Statements Calendar - Week Ahead

30 Apr 15 15:10

Earnings, Trading Statements Calendar - Week Ahead

30 Apr 15 05:15

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.